<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02629003</url>
  </required_header>
  <id_info>
    <org_study_id>H-15001910</org_study_id>
    <nct_id>NCT02629003</nct_id>
  </id_info>
  <brief_title>[11C]Cimbi-36 Dosimetry</brief_title>
  <official_title>Evaluation of Radiation Dose for [11C]Cimbi-36</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Gitte Moos Knudsen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Rigshospitalet, Denmark</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the dosimetry for the Positron Emission Tomography
      (PET) tracer [11C]Cimbi-36 in two different Carbon-11 labelling positions. This information
      will contribute to determining whether [11C]Cimbi-36 can be optimized by changing the C-11
      labelling position.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Healthy subjects wil undergo a whole-body Positron Emission Tomography (PET) scan with the
      Serotonin 2A Receptor (5-HT2A) radioligand [11C]Cimbi-36 or [11C]Cimbi-36-5 to determine the
      effective radiation dose and radiation dose for selected organs.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effective dose and absorbed dose for selected organs</measure>
    <time_frame>0 - 120 minutes</time_frame>
    <description>Based on the Positron Emission Tomography (PET) scan Time activity curves (TACs) will be generated and used for calculating the radiation doses for selected organs and over all effective radiation dose.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Measurement of radioactive metabolites in plasma</measure>
    <time_frame>0 - 120 minutes</time_frame>
    <description>Venous blood samples will be used to measure radioactive metabolites and parent compound in the blood, using radio-High-performance liquid chromatography (HPLC). The parameters will be parent radioactivity and metabolite radioactivity as a fraction (unitless) of total radioactivity in plasma over time (unit = minutes).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Measurement of radioactivity in plasma and whole blood</measure>
    <time_frame>0 - 120 minutes</time_frame>
    <description>Venous blood samples will be used to measure radioactivity in plasma and whole blood. The measurement will be given as a ratio (unitless) of plasma radioactivity relative to whole blood radioactivity over time (unit = minutes).</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>[11C]Cimbi-36</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>[11C]Cimbi-36
Maximum of 600 Mega Becquerel (MBq) or 1.5 micrograms, single dose intravenous (I.V.)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>[11C]Cimbi-36-5</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>[11C]Cimbi-36-5
Maximum of 600 Mega Becquerel (MBq) or 1.5 micrograms, single dose intravenous (I.V.)</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>[11C]Cimbi-36</intervention_name>
    <arm_group_label>[11C]Cimbi-36</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>[11C]Cimbi-36-5</intervention_name>
    <arm_group_label>[11C]Cimbi-36-5</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years of age

          -  Signed informed consent

        Exclusion Criteria:

          -  Present or former neurological disease, severe somatic or psychiatric disease, or
             medication thet can interfere with the test results.

          -  Pregnancy at the time of the scan

          -  Breastfeeding

          -  Alcohol or substance abuse

          -  Exposure to radiation (&gt;10 millisievert (mSv)) within the last year, or significant
             exposure at work

          -  Allergy to any of the substances in the Investigational medicinal product (IMP)
             formulation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gitte M Knudsen, MD, DMSc</last_name>
    <role>Study Chair</role>
    <affiliation>Neurobiology Research Unit, Rigshospitalet</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gitte M Knudsen, MD, DMSc</last_name>
    <phone>+45 35 45 67 20</phone>
    <email>gmk@nru.dk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Neurobiology Research Unit, Rigshospitalet</name>
      <address>
        <city>Copenhagen</city>
        <zip>2100</zip>
        <country>Denmark</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gitte M Knudsen, DMSc</last_name>
      <phone>+45 35456720</phone>
      <email>gmk@nru.dk</email>
    </contact>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 7, 2015</study_first_submitted>
  <study_first_submitted_qc>December 9, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 11, 2015</study_first_posted>
  <last_update_submitted>October 6, 2016</last_update_submitted>
  <last_update_submitted_qc>October 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Rigshospitalet, Denmark</investigator_affiliation>
    <investigator_full_name>Gitte Moos Knudsen</investigator_full_name>
    <investigator_title>Chair, Professor, MD, DMSc</investigator_title>
  </responsible_party>
  <keyword>Positron Emission Tomography</keyword>
  <keyword>Serotonin</keyword>
  <keyword>5-HT2A</keyword>
  <keyword>Radioligand</keyword>
  <keyword>Radiation dosimetry</keyword>
  <keyword>Radiation dosage</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

